This Week in Diabetes News
Stay connected with Diabetes Industry News — a weekly communication highlighting diabetes news, cutting-edge research, and more…
disease
Type 1 Diabetes Trigger Identified
In a groundbreaking article, scientists said they have found a switch that causes the immune system to begin destroying islet cells in type 1 diabetes…
Advertisement
Type 2 Diabetes Remission Possible With Doable Weight Loss
People who achieve a weight loss of 10% or more in the first five years after being diagnosed have the best chances of going into diabetes remission…
5 Podcasts on Type 1 Diabetes Worth a Listen
There are hundreds of thousands of podcasts out there, including ones covering type 1 diabetes. Here are five that are worth a listen…
Metformin Linked to Lower Risk of Asthma Attacks
Using metformin may lower the risk for asthma attacks in people with both diabetes and asthma, according to a new study in the journal Annals of the American Thoracic Society…
Type 2 Diabetes: What Causes Inflammation?
Glucose is not the main cause of inflammation in people with type 2 diabetes, according to a new study that challenges the conventional wisdom…
Living With Type 1 Diabetes: Four Tips to Get You Started
Have you recently been diagnosed with type 1 diabetes? Living with type 1 diabetes is definitely doable. These four tips can help.
Seven Ways to Have Fun Exercising
“Exercise is like medicine for people with diabetes.” Check out this list of ways you can get your movement in for the day — and have fun while doing it…
Autism and Type 1 Diabetes — No Link
According to a new study, children with autism are no more likely to develop type 1 diabetes than other children…
Teplizumab Granted “Breakthrough” Designation for Delaying, Preventing Type 1 Diabetes
Provention Bio, Inc. has announced that its experimental medicine teplizumab has been granted Breakthrough Therapy Designation (BTD) by the FDA for the prevention or delay of type 1 diabetes in at-risk individuals.
